Bronchoscopic and surgical treatments for people with COPD can improve their lung and exercise capacity, and quality and length of life for many years in addition to what medical treatments can achieve.
This update from PCRU guest editor and PCRS Executive Chair, Katherine Hickman, gives an overview of the latest edition of the update.
Spirometry is a component of the diagnosis and management of respiratory conditions in primary care and should ideally be performed via referral to a primary care network respiratory diagnostic service or community diagnostics centre (CDC) with expertise in the diagnosis of the most common respir
Primary care should seek to identify and provide proactive support to older people living with frailty.
Dr Fiona Mosgrove (GP with special interest in respiratory medicine) is joined by Professor Mona Bafadhel (Director for King's Centre for Lung Health and Chair of Respiratory Medicine at King's College) and Christine Mwasuku (Research Nurse and First Year PhD candidate funded by Asthma+LungUK) to
PCRS believe that it is the responsibility of every healthcare professional to treat tobacco dependency systematically and effectively. PCRS advocate that people wishing to quit using tobacco should be offered the most effective but also the least harmful methods first to support a quit attempt.
PCRS recognises a need for improvement in the timely diagnosis of people living with chronic breathlessness and generally welcomes the NHS England diagnostic pathway support tool. PCRS has some concerns that a diagnostic algorithm can communicate an oversimplification of diagnosis.
In 2023, the Medicines and Healthcare Products Regulatory Agency (MHRA) approved the use of a dual (Inhaled corticosteroid/ Formoterol) combination treatment to be used as a reliever therapy for people aged 12 and over with the therapy choice situated early in the asthma treatment pathway as an a
PCRS advocate a pragmatic approach to the pharmacological management of patients with COPD guided by the predominance of breathlessness and/or exacerbations and the presence or absence of comorbid asthma.
The report explored the link between inequality and lung disease and the primary conclusions were:
A new report is showcasing the impact of a national AHSN Network programme to improve access to FeNO testing for asthma diagnosis. Fractional exhaled Nitric Oxide (FeNO) tests are simple, non-invasive tests to support the diagnosis of asthma.
The PCRS Patient Reference Group (PRG) is a small group of people with respiratory conditions who support PCRS to ensure that we always try to embed the patient perspective in our work and consider the holistic management of patients.
Have you booked your place at this year’s conference yet? Early bird registration is now open for you to secure your place and join us in Telford for the UK’s leading respiratory conference for clinicians working in primary, community, and integrated care.